Even low-androgen triple-negative breast cancer responds to anti-androgen therapy
A University of Colorado Cancer Center study published in the journal Molecular Cancer Therapeutics shows that only about 1 percent of triple-negative breast cancer cells in a tumor must be...
Linear Mode
